SCHEMBL24059784

SCHEMBL24059784

Cc1ccc([S+]([O-])n2cc(-c3ncc(F)c(N)n3)c3cc(Cl)cnc32)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18629226 0.91 DCK (0.31) —
SCHEMBL22838097 0.90 CYP2C9 (0.32) —
SCHEMBL18051888 0.87 PIM1 (0.39) —
SCHEMBL10304064 0.79 PTPN11 (0.42) —
SCHEMBL18629001 0.77 PDK1 (0.38) —
SCHEMBL18629110 0.76 IDO1 (0.33) —
SCHEMBL24059785 0.74 — —
SCHEMBL24059747 0.72 IDO1 (0.30) —
SCHEMBL21014903 0.71 NPC1 (0.31) —
SCHEMBL16728464 0.69 PTPN11 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3427738-B1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMA (US) 2021-12-01 — — EP disclosed
Send feedback